Aldo Marrone

3.6k total citations · 1 hit paper
81 papers, 2.0k citations indexed

About

Aldo Marrone is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Aldo Marrone has authored 81 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 57 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Aldo Marrone's work include Hepatitis C virus research (56 papers), Liver Disease Diagnosis and Treatment (45 papers) and Hepatitis B Virus Studies (36 papers). Aldo Marrone is often cited by papers focused on Hepatitis C virus research (56 papers), Liver Disease Diagnosis and Treatment (45 papers) and Hepatitis B Virus Studies (36 papers). Aldo Marrone collaborates with scholars based in Italy, United States and United Kingdom. Aldo Marrone's co-authors include Luigi Elio Adinolfi, Luca Rinaldi, Rosa Zampino, Luciano Restivo, Barbara Guerrera, Marco Ciotti, Ida S. Owens, Riccardo Nevola, Giuseppe Ruggiero and Ferdinando Carlo Sasso and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Aldo Marrone

78 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors of early and late hepatocellular carcinoma recurrence

2023 102 citations Riccardo Nevola, Maria Rosaria Alfano et al. World Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aldo Marrone Italy	22	1.3k	1.2k	235	179	166	81	2.0k
Yoav Lurie Israel	25	1.5k 1.2×	1.3k 1.1×	160 0.7×	241 1.3×	220 1.3×	84	2.4k
Ming‐Ling Chang Taiwan	22	1.2k 0.9×	1.1k 0.9×	302 1.3×	80 0.4×	120 0.7×	121	1.9k
Conrado Fernández‐Rodríguez Spain	25	1.5k 1.1×	1.5k 1.2×	346 1.5×	242 1.4×	118 0.7×	93	2.5k
Amanda Nicoll Australia	24	964 0.7×	795 0.6×	132 0.6×	162 0.9×	110 0.7×	92	2.1k
Makoto Oketani Japan	24	1.1k 0.9×	1.2k 0.9×	248 1.1×	188 1.1×	56 0.3×	68	1.9k
V. Canva France	21	1.4k 1.0×	1.2k 1.0×	110 0.5×	215 1.2×	71 0.4×	58	1.8k
Massimo Colombo Italy	15	1.6k 1.2×	1.3k 1.0×	125 0.5×	337 1.9×	73 0.4×	26	2.0k
Hiroki Sakaguchi Japan	18	1.1k 0.8×	742 0.6×	264 1.1×	184 1.0×	86 0.5×	77	1.5k
Yoshio Tokumoto Japan	22	1.1k 0.9×	840 0.7×	216 0.9×	243 1.4×	41 0.2×	124	1.6k
Jean‐Charles Duclos‐Vallée France	29	1.5k 1.1×	1.7k 1.3×	220 0.9×	109 0.6×	275 1.7×	116	2.5k

Countries citing papers authored by Aldo Marrone

Since Specialization

Citations

This map shows the geographic impact of Aldo Marrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Marrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Marrone more than expected).

Fields of papers citing papers by Aldo Marrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Marrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Marrone. The network helps show where Aldo Marrone may publish in the future.

Co-authorship network of co-authors of Aldo Marrone

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Marrone. A scholar is included among the top collaborators of Aldo Marrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Marrone. Aldo Marrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adinolfi, Luigi Elio, Aldo Marrone, Luca Rinaldi, et al.. (2025). Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management. Exploration of Medicine. 5 indexed citations

Adinolfi, Luigi Elio, Aldo Marrone, Antonio Izzi, & Antonio Craxı̀. (2025). Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes. Journal of Clinical and Experimental Hepatology. 16(1). 103411–103411.

Stasio, Dario Di, Agostino Guida, Antonio Romano, et al.. (2024). Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review. Journal of Clinical Medicine. 13(14). 4012–4012. 6 indexed citations

Caturano, Alfredo, Anna Di Martino, Gaetana Albanese, et al.. (2024). The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study. Acta Diabetologica. 62(6). 891–901. 2 indexed citations

Cozzolino, Domenico, Ciro Romano, Celestino Sardu, et al.. (2023). Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome. Journal of Clinical Medicine. 12(17). 5691–5691. 1 indexed citations

Caturano, Alfredo, Raffaele Galiero, Giuseppe Loffredo, et al.. (2023). Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study. Biomedicines. 11(2). 322–322. 30 indexed citations

Romano, Ciro, Domenico Cozzolino, Riccardo Nevola, et al.. (2023). Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients. Viruses. 15(9). 1904–1904. 4 indexed citations

Nevola, Riccardo, Domenico Beccia, Simona Imbriani, et al.. (2023). Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination. World Journal of Gastroenterology. 29(5). 800–814. 4 indexed citations

Nevola, Riccardo, Domenico Beccia, Valerio Rosato, et al.. (2023). HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis. International Journal of Molecular Sciences. 24(8). 7651–7651. 16 indexed citations

10.

Messina, Vincenzo, Riccardo Nevola, Antonio Izzi, et al.. (2022). Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19. Scientific Reports. 12(1). 5771–5771. 9 indexed citations

11.

Niro, Grazia Anna, Antonina Smedile, Rosanna Fontana, et al.. (2016). HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Alimentary Pharmacology & Therapeutics. 44(6). 620–628. 40 indexed citations

12.

Ruggiero, Giuseppe, Aldo Marrone, Luigi Elio Adinolfi, et al.. (2016). Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study.. PubMed. 24(4). 278–286. 1 indexed citations

13.

Coppola, Nicola, Rosa Zampino, Giulia Bellini, et al.. (2016). CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. Digestive and Liver Disease. 48(11). 1364–1369. 7 indexed citations

14.

Zampino, Rosa, Loredana Alessio, Aldo Marrone, et al.. (2015). Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment.. PubMed. 23(2). 134–9. 2 indexed citations

15.

Zampino, Rosa, Aldo Marrone, Luciano Restivo, et al.. (2013). Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World Journal of Hepatology. 5(10). 528–528. 174 indexed citations

16.

Coppola, Nicola, Aldo Marrone, Mariantonietta Pisaturo, et al.. (2013). Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection. European Journal of Clinical Microbiology & Infectious Diseases. 33(4). 559–567. 36 indexed citations

17.

Durante‐Mangoni, Emanuele, Rosa Zampino, Aldo Marrone, et al.. (2006). Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor‐α in chronic hepatitis C patients. Alimentary Pharmacology & Therapeutics. 24(9). 1349–1357. 95 indexed citations

18.

Zampino, Rosa, Aldo Marrone, Enrico Ragone, et al.. (2005). Heart Transplantation in Patients with Chronic Hepatitis B: Clinical Evolution, Molecular Analysis, and Effect of Treatment. Transplantation. 80(9). 1340–1343. 10 indexed citations

19.

Zampino, Rosa, Aldo Marrone, Emanuele Durante‐Mangoni, et al.. (2004). Anti‐envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co‐infection and interferon treatment. Journal of Medical Virology. 73(1). 33–37. 7 indexed citations

20.

Zampino, Rosa, Aldo Marrone, Grazia Cirillo, et al.. (2002). Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment. Journal of Viral Hepatitis. 9(3). 183–188. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact